Seyfarth Represents Indegene In Strategic Acquisition of BioPharm

October 1, 2025 – Seyfarth Shaw LLP represented Indegene in the strategic acquisition of BioPharm, a Pennsylvania-based specialized marketing services agency and part of Omnicom Health Group. The acquisition by ILSL Inc., a subsidiary of Indegene Limited, strengthens Indegene’s commercialization portfolio with AdTech, combining AI and digital advertising, enabling pharma companies to drive more precise, scalable, and measurable outcomes. Further, this solidifies Indegene’s position as a true category leader in data-driven Omnichannel and Media Space.

The team of Seyfarth lawyers was led by Suzanne Saxman and Breanne Vaclavik, with support from Chris Duffy and others.

“We’re proud of our long-standing relationship with Indegene and thrilled to support this next step in their growth. The deal underscores Seyfarth’s strength in middle-market M&A and our deep experience across healthcare and business services,” said Saxman.

You can view more details about the transaction here.

 

About Indegene

Indegene Limited (BSE: 544172, NSE: INDGN) is the tech-native, life sciences specialist orchestrating the path from commercialization strategy through execution. Trusted by the world’s top 20 biopharma companies across the value chain - from clinical and medical through commercial - Indegene helps life sciences leaders move at the speed of their ambition with #PractitionerLevelConfidence. Indegene’s difference comes from integrating deep domain knowledge, contextualized technology and operational excellence, built over 25 years. When bold life sciences leaders want to take breakthrough therapies to market faster, maximize impact, and create seamless experiences for patients and physicians, they count on Indegene. Orchestrate your path at www.indegene.com

About BioPharm

Founded in New Hope, Pennsylvania in 2005, BioPharm Communications helps brand teams at pharmaceutical and biotech companies execute customized marketing campaigns through a comprehensive portfolio of proprietary program offerings. As part of a customized 360º strategy, BioPharm educates healthcare professionals through the Peer-to-Peer360º suite, differentiates and builds brand awareness through the brand360° campaign approach, and tracks engagement instantly via the Insights360° customer relationship management platform. Visit https://www.biopharmcommunications.com for more.

About Seyfarth

With more than 975 lawyers across 17 offices, Seyfarth Shaw LLP provides top-tier advisory, litigation, and transactional legal services to clients worldwide.